Median I-FABP serum levels were significantly higher in SSc patients compared to HC [1221.50 pg/ml (IQR 697.60–1836) vs. 460.45 pg/ml (IQR 327.75–1802.10), p < 0.05] (Fig. 1D). Here, FABP2 is linked to systemic sclerosis.